Skip to main content
PepStack
Blutwerte · Marker

ALT (GPT)

Alanin-Aminotransferase · ALAT · GPT · SGPT

Leberwerte
Einheit:
IU/L
Abbreviation
ALT / GPT

ALT measures the activity of the enzyme alanine aminotransferase, which is involved in amino acid metabolism in the liver.

Reference Ranges

Reference
756IU/L
7
10
30
56
LowNormalHigh
Reference
Optimal
Unit · IU/L

Reference ranges may vary slightly between laboratories. ALT levels can be higher in males compared to females.

Overview

Übersicht

Alanine aminotransferase (ALT), also known as glutamate pyruvate transaminase (GPT), is an enzyme primarily found in the liver. It plays a crucial role in amino acid metabolism by catalyzing the conversion of alanine and alpha-ketoglutarate to pyruvate and glutamate. Clinically, ALT is a key marker for liver health, as elevated levels often indicate liver damage or inflammation. Conditions such as non-alcoholic fatty liver disease (NAFLD), hepatitis, and liver cirrhosis are commonly associated with increased ALT levels. Researchers have also observed that ALT levels can be elevated in cases of muscle injury and certain infections, such as infectious mononucleosis. For athletes and biohackers, monitoring ALT can provide insights into liver function and overall metabolic health. While ALT is not directly linked to athletic performance, maintaining optimal liver function is crucial for metabolic efficiency and recovery. However, ALT levels can be influenced by factors such as recent physical activity, medications, and alcohol consumption, which may confound results. Therefore, it is recommended to interpret ALT levels in conjunction with other liver function tests and consider lifestyle factors that may affect the readings.

Klinische Bedeutung

Elevated ALT levels typically indicate liver damage or inflammation, which can occur in conditions such as hepatitis, NAFLD, and cirrhosis. Low ALT levels are generally not clinically significant but may occur in cases of vitamin B6 deficiency.

Dynamics

Trend Interpretation

Rising Values

Progressively rising ALT values suggest worsening liver function and warrant further investigation. Retest in 4 weeks if outside optimal range.

Falling Values

Falling ALT values may indicate improvement in liver health or resolution of an acute liver injury.

Re-test Interval

4 weeks if outside optimal range

Etiology

Causes — High & Low

Cause

Elevated Levels

  • Liver disease
  • Hepatitis
  • Alcohol consumption
  • Muscle injury
  • Infectious mononucleosis
Cause

Low Levels

  • Vitamin B6 deficiency
  • Chronic kidney disease
  • Malnutrition
  • Severe liver damage
Protocol

How to Optimize

Lever

Lifestyle

  • Regular exercise
  • Avoid excessive alcohol consumption
  • Maintain a healthy weight
Lever

Nutrition

  • Consume a balanced diet rich in fruits and vegetables
  • Limit intake of processed foods
  • Ensure adequate hydration
Lever

Supplementation

  • Milk thistle
  • N-acetylcysteine

Note:

Consult a healthcare provider before making significant lifestyle changes, especially if liver disease is suspected.

Testing Guidelines

Fasting Not Required
Not Time-Sensitive

ALT levels can vary throughout the day; morning samples are preferred for consistency.

Testing Frequency

Annually for healthy adults, more frequently if liver disease is suspected.

Interfering Factors

  • Recent intense exercise
  • Certain medications
  • Alcohol consumption

Open Research Questions

Current research suggests that the reference ranges for ALT may not adequately reflect the severity of liver disease, particularly in non-alcoholic fatty liver disease (NAFLD), where its predictive value remains debated. Researchers have not yet established optimal ALT targets for monitoring liver health or the influence of confounding factors such as obesity and metabolic syndrome. Additionally, clinical questions remain unanswered regarding the role of ALT in predicting cognitive decline in conditions like atrial fibrillation.

23 Research Publications

183

Total Citations

16

Human/RCT

2.0

Avg. Influence

2025

Latest

Sort
Filter
#01

Use of enzymes for the diagnosis of alcohol-related organ damage.

ReviewInfluence3.0
88
Researchers discussed the challenges in using serum enzyme levels, including ALT, for diagnosing alcohol-related organ damage. They noted that while elevated ALT can indicate liver injury, it is not specific enough for definitive diagnosis, necessitating a combination of tests for better accuracy.
View on PubMed
#02

Sarcoidosis of the liver: to treat or not to treat?

HumanInfluence2.0
45
This study explored the effects of ursodeoxycholic acid (UDCA) on liver function in patients with hepatic sarcoidosis. Researchers found that serum liver tests, including alanine aminotransferase (ALAT), improved in patients treated with UDCA compared to those who received no treatment. The study involved 17 patients and highlighted the need for further research.
View on PubMed
#03

Covid-19: contribution of clinical characteristics and laboratory features for early detection of patients with high risk of severe evolution.

Human
16
Researchers identified clinical and laboratory features, including ALT levels, that could predict severe outcomes in COVID-19 patients. The study found that elevated ALT was among several biomarkers associated with worse prognosis, aiding in the early detection of high-risk patients.
View on PubMed
#04

Non-alcoholic fatty liver disease and correlation of serum alanin aminotransferase level with histopathologic findings.

HumanInfluence1.0
8
Researchers investigated the correlation between serum ALT levels and histopathological findings in patients with non-alcoholic fatty liver disease (NAFLD). They found that ALT levels had little predictive value for the severity of NAFLD, suggesting that other factors may be more relevant in assessing disease severity.
View on PubMed
#05

Haematology and clinical blood chemistry in harbour porpoises (Phocoena phocoena) from the inner Danish waters.

Animal
6
This research presented hematology and blood chemistry data from harbour porpoises to assess population health. Researchers noted that alanine aminotransferase (ALAT) values were lower in captive porpoises compared to free-ranging individuals, suggesting environmental influences on health markers. The study included blood samples from both wild and captive porpoises.
View on PubMed
#06

Reference intervals for 12 clinical laboratory tests in a Danish population: The Lolland-Falster Health Study.

Human
6
Researchers established reference intervals for various laboratory tests, including ALT, in a Danish population. They found that local reference limits for ALT differed from previously established norms, indicating the importance of population-specific data for accurate laboratory assessments.
View on PubMed
#07

IL-28 and IL-29 as protective markers in subject with dengue fever.

Human
5
This study assessed the role of interleukins IL-28 and IL-29 in dengue fever patients. Researchers found that higher levels of these interleukins were associated with lower alanine aminotransferase (ALAT) levels, indicating better liver function. The study included 45 dengue patients and 24 controls.
View on PubMed
#08

[Hypertriglyceridemia--diagnostics, risk and treatment].

Review
3
This review article discussed hypertriglyceridemia and its associated laboratory evaluations, including alanine aminotransferase (ALAT). Researchers emphasized the importance of measuring ALAT among other parameters to assess metabolic health. The article provided insights into the diagnostics and risk factors related to hypertriglyceridemia.
View on PubMed
#09

Biomarker and cognitive decline in atrial fibrillation: a prospective cohort study.

Krisai Philipp, et al. · Scientific reports · 2025

Human
3
Researchers examined the relationship between various biomarkers, including ALT, and cognitive decline in patients with atrial fibrillation. They found that 6.5% of patients experienced cognitive decline over four years, with specific biomarkers like GDF-15 and ALT showing significant associations. The study suggests that inflammation and neuronal damage may contribute to cognitive decline in this population.

Key findings

  1. 01Researchers observed that patients with cognitive decline were more likely to have permanent AF and a history of stroke.
  2. 02The biomarkers GDF-15, Cystatin C, and high-sensitivity Troponin T were strongly associated with cognitive decline.
  3. 03The best prediction model for cognitive decline included several biomarkers, indicating complex underlying mechanisms such as inflammation and neuronal damage.
View on PubMed
#10

[Chronic polyneuropathy--evaluation and diagnosis].

Review
2
This review focused on the evaluation and diagnosis of chronic polyneuropathy, emphasizing the importance of routine laboratory assessments. Researchers highlighted that tests including alanine aminotransferase (ALAT) should be conducted to identify common causes of polyneuropathy. The article provides guidelines for physicians to approach diagnosis effectively.
View on PubMed

Publication Trend

Research publications about ALT (GPT) over time

9total
1
'87
1
'92
2
'01
1
'07
1
'11
1
'20
1
'21
1
'25

Track your bloodwork in PepStack

Log lab results, track trends and optimize your biomarkers over time.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer